Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bionomics
Biotech
Bionomics' midphase PTSD clinical trial hits primary endpoint
Investors sent Bionomics' share price up almost 100% on the strength of phase 2 data in post-traumatic stress disorder.
Nick Paul Taylor
Sep 28, 2023 7:08am
Bionomics' lead asset fails to reduce public speaking anxiety
Dec 19, 2022 9:00am
Roche's executive dominoes continue to tip—Chutes & Ladders
Dec 16, 2022 9:30am
